Clinical Trial Update: GM1 and GM2 Gangliosidosis PROspective Neurological Disease TrajectOry Study (PRONTO)

View source ↗

Summary

A clinical trial update for the PROspective Neurological Disease Trajectory Study (PRONTO) by Azafaros reports completion of the GM1 and GM2 gangliosidosis tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gm1 Gangliosidosis
• Sandhoff Disease
• Tay-sachs Disease

Snippet

Sponsor: Azafaros A.G. | Conditions: GM1 Gangliosidosis, Sandhoff Disease | Status: COMPLETED